Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Levine

Showing results (721-730 of 799) with videos related to

Pageof 80
Sort By:
Journal of the American Heart Association|February 13, 2024
Rising Cardiac Troponin: A Prognostic Biomarker for Mortality After Acute Ischemic StrokeMichela Rosso, Srinath Ramaswamy, Yohannes Mulatu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2015
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and CilengitidePeter H O'Donnell, Sanja Karovic, Theodore G Karrison, et al.
The Oncologist|May 6, 2018
Predictors of Location of Death for Children with Cancer Enrolled on a Palliative Care ServiceErica C Kaye, Samantha DeMarsh, Courtney A Gushue, et al.
The Journal of Arthroplasty|July 1, 2017
Determining the Threshold for HbA1c as a Predictor for Adverse Outcomes After Total Joint Arthroplasty: A Multicenter, Retrospective StudyMajd Tarabichi, Noam Shohat, Michael M Kheir, et al.
Pediatric Blood & Cancer|January 18, 2025
Impacts of Ethical Dilemmas and Moral Distress in Pediatric Hematology Oncology NursesArshia Madni, Deena R Levine, Kimberly E Sawyer, et al.
Annals of Neurology|June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeJ Broderick, M Lu, C Jackson, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trialYufeng Wang, Yi Zheng, Yasong Du, et al.
Neuroepidemiology|October 26, 2012
Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological studyZoe Arvanitakis, Robin L Brey, Jacob H Rand, et al.
Environmental Health Perspectives|October 26, 2001
Emerging areas of research reported during the CDC National Conference on Pfiesteria: from biology to public healthC Rubin, M A McGeehin, A K Holmes, et al.
Drug and Alcohol Dependence|April 12, 2008
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disordersTimothy E Wilens, Lenard A Adler, Margaret D Weiss, et al.
Pageof 80

Showing results (721-730 of 799) with videos related to

Sort By:
Pageof 80
Journal of the American Heart Association|February 13, 2024
Rising Cardiac Troponin: A Prognostic Biomarker for Mortality After Acute Ischemic StrokeMichela Rosso, Srinath Ramaswamy, Yohannes Mulatu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2015
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and CilengitidePeter H O'Donnell, Sanja Karovic, Theodore G Karrison, et al.
The Oncologist|May 6, 2018
Predictors of Location of Death for Children with Cancer Enrolled on a Palliative Care ServiceErica C Kaye, Samantha DeMarsh, Courtney A Gushue, et al.
The Journal of Arthroplasty|July 1, 2017
Determining the Threshold for HbA1c as a Predictor for Adverse Outcomes After Total Joint Arthroplasty: A Multicenter, Retrospective StudyMajd Tarabichi, Noam Shohat, Michael M Kheir, et al.
Pediatric Blood & Cancer|January 18, 2025
Impacts of Ethical Dilemmas and Moral Distress in Pediatric Hematology Oncology NursesArshia Madni, Deena R Levine, Kimberly E Sawyer, et al.
Annals of Neurology|June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeJ Broderick, M Lu, C Jackson, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trialYufeng Wang, Yi Zheng, Yasong Du, et al.
Neuroepidemiology|October 26, 2012
Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological studyZoe Arvanitakis, Robin L Brey, Jacob H Rand, et al.
Environmental Health Perspectives|October 26, 2001
Emerging areas of research reported during the CDC National Conference on Pfiesteria: from biology to public healthC Rubin, M A McGeehin, A K Holmes, et al.
Drug and Alcohol Dependence|April 12, 2008
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disordersTimothy E Wilens, Lenard A Adler, Margaret D Weiss, et al.
Pageof 80